| Statement |
1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance
shall also be indicated, e.g., dividend yield, etc.):
Common shares of PHOENIX TECHNOLOGIES INTERNATIONAL, LLC
2.Date of occurrence of the event:2020/09/14~2021/06/18
3.Amount, unit price, and total monetary amount of the transaction:
Transaction volume: N/A
Price per unit: N/A
Total purchase price: US$ 11,500,000
4.Trading counterparty and its relationship with the Company (if the trading counterparty is a natural person and
furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed):
Trading counterpart : PHOENIX TECHNOLOGIES INTERNATIONAL, LLC
Relationship with the company : the wholly owned subsidiary
5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing
the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and
the trading counterparty, and the previous date and monetary amount of transfer: Capital injection / NIL
6.Where an owner of the underlying assets within the past five years has been a related party of the Company, the announcement
shall also include the date and price of acquisition and disposal by the related party, and its relationship with
the Company at the time of the transaction:N/A
7.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed creditor’s rights;
if creditor's rights over a related party, announcement shall be made of the name of the related party and the book amount of
the creditor's rights, currently being disposed of, over such related party):N/A
8.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (those with deferral should
provide a table explaining recognition):N/A
9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract,
and other important terms and conditions:Cash / NIL / NIL
10.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price negotiation),
the reference basis for the decision on price, and the decision-making unit: Capital injection / Capital injection / The BOD
11.Net worth per share of the Company's underlying securities acquired or disposed of:N/A
12.Cumulative no.of shares held (including the current transaction), their monetary amount, shareholding percentage,
and status of any restriction of rights (e.g., pledges), as of the present moment: N/A / NT$ 280,926,245 / 100% / NIL
13.Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing
the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity attributable to owners of
the parent as shown in the most recent financial statement and working capital as shown in the most recent
financial statement as of the present:
Current ratio to total assets: 4.74%
Current ratio to shareholders’ equity: 7.58%
The operating capital as shown in the most recent financial statement: NT$ 7,876,631,000
14.Broker and broker's fee:N/A
15.Concrete purpose or use of the acquisition or disposal: To increase investment
16.Any dissenting opinions of directors to the present transaction:NIL
17.Whether the counterparty of the current transaction is a related party:Yes
18.Date of the board of directors resolution:2021/06/18
19.Date of ratification by supervisors or approval by the Audit Committee:NA
20.Whether the CPA issued an unreasonable opinion regarding the current transaction:N/A
21.Name of the CPA firm:N/A
22.Name of the CPA:N/A
23.Practice certificate number of the CPA:N/A
24.Whether the transaction involved in change of business model:No
25.Details on change of business model:N/A
26.Details on transactions with the counterparty for the past year and the expected coming year:
Capital was injected to PHOENIX TECHNOLOGIES INTERNATIONAL, LLC with US$ 6,500,000 in September 2020.
27.Source of funds:Equity capital 28.Any other matters that need to be specified:NIL
|
